Legal Opinion
In Re Brand Name Prescription Drugs Antitrust Litigation
Court of Appeals for the Seventh Circuit
Decided August 9, 1999No. 99-1167PublishedCited by 60 opinions
1Opinion of the Court
POSNER, Chief Judge.
Retail pharmacies brought suit under section 1 of the Sherman Act, 15 U.S.C. § 1, against manufacturers and wholesalers of brand-name prescription drugs, charging that the defendants had conspired to deny discounts to the pharmacies. An additional claim emerged during the course of the litigation' — that the defendants had conspired to peg price increases to changes in the Consumer Price Index. After an earlier decision by this court resolved some of the issues, see 123 F.3d 599 (7th Cir.1997), the plaintiffs settled with a number of the defendants and went to trial before…
2Cases cited36 opinions
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- United Mine Workers v. PenningtonSupreme Court of the United States · 1965
- Illinois Brick Co. v. IllinoisSupreme Court of the United States · 1977
31 more not listed; retrieve them via the Exa API.
3Cited by60 opinions
- E.I. Du Pont De Nemours & Co. v. Kolon Industries, Inc.Court of Appeals for the Fourth Circuit · 2011
- In Re High Fructose Corn Syrup Antitrust Litigation. Appeal of a & W Bottling, Inc.Court of Appeals for the Seventh Circuit · 2002
- Joblove v. Barr Labs. Inc.Court of Appeals for the Second Circuit · 2005
- In re Cardizem CD Antitrust LitigationDistrict Court, E.D. Michigan · 2003
- Toys "R" US, Inc. v. Federal Trade CommissionCourt of Appeals for the Seventh Circuit · 2000
55 more not listed; retrieve them via the Exa API.